CONMED Corp
CNMD- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000816956
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
258
- +4 vs. Q1 2026
- Total value $1.26B
Superinvestors holding CNMD
1
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by CNMD insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Nov 21, 2025 | Glaze RichardChief Information Officer | SSaleCommon Stock | −257 | $41.21 | −$10.59K | 0 | −100.0% | SEC10b5-1 |
| Nov 7, 2025 | Nov 6, 2025 | Garner Todd WExecutive Vice President & CFO | SSaleCommon Stock | −3.5K | $43.00 | −$150.5K | 1.84K | −65.6% | SEC10b5-1 |
| Sep 15, 2025 | Sep 12, 2025 | Farkas CharlesDirector | SSaleCommon Stock | −2K | $53.5265 | −$107.05K | 14.86K | −11.9% | SEC |
| Aug 8, 2025 | Aug 7, 2025 | Garner Todd WExecutive Vice President & CFO | SSaleCommon Stock | −598 | $52.45 | −$31.37K | 0 | −100.0% | SEC |
| May 6, 2025 | May 5, 2025 | Farkas CharlesDirector | SSaleCommon Stock | −4K | $56.94 | −$227.76K | 16.35K | −19.7% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in CNMD at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,820,739 | $157.78M | 0.00% | −4,434−0.1% | Reduced |
| EARNEST PARTNERS LLC | 2,505,295 | $82M | 0.30% | −64,358−2.5% | Reduced |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,188,761 | $71.64M | 0.00% | +112,344+5.4% | Added |
| OAKTREE CAPITAL MANAGEMENT LPSuperinvestorOaktree Capital | – | $52.46M | 0.99% | – | – |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,579,917 | $51.71M | 0.14% | −61,849−3.8% | Reduced |